Expression and Localisation of Wave Isoforms in Human Schwann and Schwannoma Cells by Schmid, M.
The Plymouth Student Scientist, 2008, 1, (2), 19-29 
ISSN 1754-2383 [Online] 
©University of Plymouth 
 [19] 
 
         
 
Expression and Localisation of Wave Isoforms 
in Human Schwann and Schwannoma Cells  
 
Marei Caroline Schmid  
2008 
Project Advisor: Stephen Thompson, School of Biological Sciences, University of 
Plymouth, Drake Circus, Plymouth, PL4 8AA 
 
Abstract 
Schwannoma, the main tumours associated with Neurofibromatosis Type II, are caused by 
loss of function mutations in the NF2 gene, encoding for the tumour suppressor Merlin. 
Schwannoma cells display protrusive structures, due to deregulation of the cytoskeleton. The 
cytoskeleton is controlled by small Rho GTPases, such as Rac1 and Cdc42, known to be 
activated continuously in merlin-deficient human schwannoma cells (NF2-/-). Downstream 
Rac signalling leads to the activaton of Wave signalling complexes, which have been shown 
to bind and activate the Arp2/3 complex, a crucial regulator of the actin cytoskeleton that is 
involved in formation of protrusive structures. This investigation used an established NF2 
model of primary human Schwann and schwannoma cells to investigate the expression and 
localisation of Pan-Wave and Wave-2. Using commercially available antibodies, 
immunocytochemistry (ICC) labelling for Pan-Wave showed an atypical distribution in both 
human Schwann and schwannoma cells. Western blotting for Pan-Wave in NF2-/- 
(schwannoma cells) also showed multiple non-specific bands. ICC for Wave2 in human 
schwannoma showed atypical distribution of this isoform. Western blotting for Wave2 using 
whole Schwann cell lysate, schwannoma lysate and HL60 cell lysate confirmed the non-
specificity of the antibody. Therefore the specificity regarding commercially available 
antibodies is discussed. 
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Schwannoma tumours are the hallmark of 
Neurofibromatosis Type II and are 
characterized by loss of function mutations 
in both alleles of the NF2 gene (OMIM 
101000) encoding for the tumour 
suppressor Merlin (Rouleau et al., 1996). 
Merlin, physiologically expressed in a 
variety of cell types, is thought to mediate 
contact inhibition of growth by blocking 
recruitment of Rac to the membrane 
(Okada T. et al., 2007) and suppresses 
Rac dependent signalling (Shaw, RJ. et 
al., 2001).  Moreover merlin blocks 
signalling through integrins the 
Ras/Raf/Mek (Lim, JY. et al., 2006) and 
P13/AKT pathway implicated with 
proliferation and cell survival (Okada, T. et 
al., 2007). Loss of Merlin in Schwann cell 
leads to the formation of schwannoma. 
Schwanoma cells display abnormalities 
such as increased proliferation rate, 
reduced apoptotic response (Utermark, T. 
et al., 2005), loss of contact inhibition of 
growth (Lallemande D. et al., 2003; Flaiz 
C. et al., 2008), increased cell spreading, 
adhesion and dynamic protrusive 
structures (Pelton, P.H. et al., 1998) due to 
increased actin remodelling (reviewed in 
Hanemann, C.O., 2007). 
 
The formation of protrusive structures, 
such as membrane ruffles, lamellipodia 
and filopodia has been shown to be 
controlled by members of the small Rho 
GTPase family like Rho, Rac and Cdc42 
(Hall, A. et al., 1998). RhoGTPases control 
the cytoskeleton and as they cycle 
between an active GTP bound state and 
an inactive GDP bound state, can be 
referred to as molecular switches. It is 
understood that the rate at which GTP is 
cycled is dependent on GEFs (Guanine 
exchange factor) and GAPs (GTPase 
activating proteins) (Hall, A. et al., 2005). 
Co-ordinated Rac activation has been 
shown to mediate myelination in normal 




Rho GTPase Effectors 
Rac and Cdc42 regulate the actin 
cytoskeleton and the formation of 
protrusive structures by activation of the 
Arp2/3 (Actin related protein) complex. 
The Arp2/3 complex, consisting of seven 
subunits, is capable of binding to existing 
actin filaments upon activation (Machesky, 
L. et al., 1999), thereby inducing the 
nucleation of new actin filaments 
implicated with the formation of the highly 
branched actin filament network in 
protrusive structures. The Arp2/3 complex 
becomes activated through WASP 
(Wiskott-Aldrich syndrome proteins) and 
WAVE (Wiskott-Aldrich verprolin 
homologous) proteins (Fig.1), which are 
downstream effectors of Cdc42 and Rac. 
Rac is thought to activate Wave indirectly 
through PIR121 (p53 inducible messenger 
RNA) (reviewed in Bompard, G and 
Caron, C., 2004), whereas Cdc42 is 
capable of binding WASp directly  
via the GTPase binding domain (GBD) a 
domain absent in Wave (Miki, H. et al., 
1998). WASp, N-WASp and Wave 
proteins belong to the family of Wiskott-
Aldrich syndrom proteins (WASP) and 
share the VCA module consisting of 3 
domains known to be required for Arp2/3 
complex activation.  
 
Wave  
Wave proteins have been described to 
exist as three isoforms in mammalian 
systems (reviewed in Sonderling, S.H and 
Scott, J.D, 2003), namely Wave1, Wave2 
and Wave3. 
Expression of isoforms varies between 
different tissues, cell types respectively, 
and in rat Schwann cells Wave 2 has been 
described as the main isoform (Bacon et 
al., 2007).  Each Wave protein is bound in 
a complex with other proteins such as 
HSPC300, PIR121 (p53 inducible 
messenger RNA), Nap1 (Nck-associated 
protein), and Abi1 (Abl interactor). These 
pentameric Wave complexes are thought 
to partially disassemble upon activation. 
And some isoform specific variation has 
been described concerning these 
complexes, and their regulation. Despite 
these differences PIR121, associated with  
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all isoforms, has been brought forward as 
the link between Rac and Wave activation, 
due to its sequence homology to p140Sra- 
(specific Rac1-associated protein) 
(reviewed in Bompard, G and Caron, C., 
2004). 
 
The underlying ultimate aim of any study 
in any disease model is to understand the 
mechanisms involved and to identify a 
molecular target for treatment. Molecular 
targets are proteins involved in signalling 
pathways, and are activated or expressed 
at higher levels compared to the wild type.  
In addition proteins can be mislocalised, 
altering their wild type function. It was the 
aim of this project to investigate 
expression (Western blot analysis) and 
localisation (Immunocytochemistry) of 
Wave in the context of human 
schwannoma (Neurofibromatosis Type 2). 
In order to obtain comparative data, 
experiments were also performed in 
normal Schwann cells. Using this model it 
has already been shown that Rac and 
Cdc42 are activated at higher levels 
leading to higher levels of Arp2/3 activity in 
schwannoma cells (Flaiz et al., 2007, 
Kämpchen et al. 2003). By combining 
westerblot analysis and 
immunocytochemistry, using the same 
antibody, results can be qualitative and 
quantitative verified. 
 
METHODS AND MATERIALS 
 
In vitro schwannoma Model 
This model allows the comparison of 
human primary Schwann cells and 
Schwannoma cells (donated from 
Neurofibromatosis II patients), and 
requires any experiment to be repeated 
three times in cells with different origin 
(three pairs of NF2+/+ and NF2-/-). 
Not all investigations have involved both 
cell types. Only if considered favourable 
have human Schwann cells been used (as 
these cells are derived from healthy 
donors and are difficult to obtain.) Some 
antibody optimization has been performed 
using RT4 (Rat Schwann cells).  
A final experiment in the Wave-2 
investigation has been carried out using 
three pairs of Schwann and schwannoma 
cells derived from independent origin. 
 
Cell Culture 
(All chemicals from Sigma-Aldrich unless 
indicated otherwise.) 
RT4 
RT4 (rat schwannoma) cells were cultured 
from frozen aliquots. Cells were thawed 
from liquid nitrogen (-273º C) to 37º C 
gently in a water bath, before being 
transferred into 10%FCS/DMEM. The 
suspension was centrifuged for 10 minutes 
at 1500 rpm. The supernatant was 
exhausted and the pellet was 
resuspended in 10%FCS/DMEM, seeded 
in plastic dishes and incubated at 37º C 
and 5% CO2. 
Schwann /schwannoma cells from tissue  
Schwann and schwannoma cells were 
cultured according to the methods 
described by Rosenbaum, C. et al. (1998). 
Schwann cells (NF2+/+): The nerve was 
prepared by pulling the fascicles out of the 
connective tissue (adventitia) and 
incubated with medium (10%FCS/DMEM, 
400U/ml Penstrep, 1.6µM Forskolin, 
Amphotericin) for 14 days at 37º C/ 10% 
CO2. Incubation medium was changed 
every 3 days.  
Schwannoma cells (NF2-/-): Tumours 
were stripped of connective tissue and 
incubated with medium (10%FCS/DMEM, 
400U/ml Penstrep, 1.6µM Forskolin, 
Amphotericin) for 1-7 days at 37º C/ 10% 
CO2. Incubation medium was changed 
every 3 days. After incubation for the 
indicated times, digestion medium 
containing 10%FCS/DMEM, 400U/ml 
Penstrep, Dispase (Roche) and 
Collagenase was added and the 
nerve/tumour was cut into 1mm pieces 
and remained incubated in digestion 
medium for 18h (nerve) or 24 h (tumour) 
respectively at 37º C /10% CO2.  The 
pieces were then further broken down 
using a series of constricted glass Pasteur 
pipettes and the suspension was 
centrifuged for 7 minutes at 4000 rpm. The 
supernatant was exhausted and the pellet 
resuspended in growth medium consisting 
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of 10%FCS/DMEM, 100U/ml Penstrep, 
0.5µM IBMX, Amphoterecin, 2.5µg/ml 
Insulin, 0.5 µM Forskolin and 10nM Beta-
Heregulin. Cells were incubated on poly-L-
lysine/laminin coated plates (Greiner Bio 
One) for a maximum time of 1 week at 37º 
C 10% CO2. Mediums were changed after 
3 days. S-100 (Schwann Cell marker) 
staining was performed in the 1º or 2º 
passage, to assess fibroblast 
contamination (negligible at < 2%).  
 
Antibodies  
Anti-Wave/SCAR, rabbit polyclonal 
(Upstate) 
Anti-Wave-2, rabbit antiserum against C- 
NRGNVNPRKIKTRKE  200 Aa of human 
Wave-2 protein  (Upstate).  
 
Western Blotting 
Cell lysis/Protein extraction: In order to 
extract protein from the cells, also referred 
to cell lysate. Lysis buffer consisting of 
DLP, complete inhibitor (1:50) (Roche) 
and phosphatase inhibitor I and II (1:100) 
was boiled at 99ºC and applied to 
adherent cells (50µl lysis buffer per 
200.000 cells). Cells were scraped down 
and transferred to a tube, boiled at 99º C 
for 5 minutes, cooled on ice for 5 minutes 
and centrifuged for 30 minutes at 3500 
rpm and 4º C. Aliquots (20µl) were frozen 
at -80º C and used in subsequent 
investigations. 
Protein estimation: In order to measure 
protein amounts. Protein amounts were 
measured using the Bio-Rad colorimetric 
assay against a lysis buffer control. This 
step is necessary when comparing 
different cells i. e Schwann and 
schwannoma cell, and is later verified by 
the loading control. 
Electrophoresis(SDS-PAGE): In order to 
separate proteins by size.  Following the 
standard protocol 1.5mm thick 12% 
polyacrylamide resolving gels, most 
suitable for detection of proteins between 
20-120 kDa, were poured into Bio-Rad 
systems and allowed to set for 40 minutes. 
4% polyacrylamide stacking gels were 
poured on top, comb defining the loading 
wells was inserted and allowed to set for 
30 minutes at room temperature. Protein 
aliquots were boiled in their sample buffer 
(100mM Tris-HCL, 4% SDS, 20% 
Glycerol, 0.01% Bromophenol blue) for 5 
min. and cooled on ice for 5 min., before 
being loaded into the wells. Standard 
marker (containing proteins of known size) 
was loaded into the most outer well. The 
gels were run in running buffer containing 
3.03 mg/ml Tris, 14.4 mg/ml Glycine, 
1mg/ml SDS at 200V, 400mA for 45 
minutes until the dye front run off. 
Blotting (Transfer): In order to transfer 
protein from the gel to the membrane. 
PVDF membranes were cut to gel size 
and placed on the gel in a blotting 
sandwich. Blotting was run in transfer 
buffer containing 3.03mg/ml Tris, 
14.4mg/ml Glycine, 200µl/ml methanol and 
H2O  over night at 85V, 175mA and 4º C. 
Protein Detection (following the standard 
protocol) 
Blocking: in order to block unspecific 
binding sites, membranes were placed in 
blocking solution (Tris buffered saline-
Tween 20 (TBS-Tween) 5% skimmed milk 
powder, 2% Bovine albumin serum (BSA)) 
for 1 hour at room temperature on a 
rotator. 
Primary antibody: in order to detect Wave 
protein, Anti Pan-Wave (1:1000) or anti 
Wave-2 (1:500) were diluted in blocking 
solution and/or 1% BSA TBS and 
incubated with the membrane overnight at 
4º C on a rotator. Membranes were 
washed in TBS-Tween twice for 30 
minutes. 
Secondary Antibody: in order to label 
primary antibody, Goat-anti-rabbit HRP 
conjugated secondary antibody (Bio-Rad) 
at concentration (1:2500) was incubated in 
blocking solution with the membrane for 1 
hour at room temperature on a rotator. 
Membranes were washed three times in 
TBS-Tween for 5 minutes and twice in 
TBS for 10 minutes 
ECL detection: in order to detect protein 
bound secondary antibody on the 
membrane, ECL Plus (Amersham) 
solution was prepared and applied to the 
membrane for 5 minutes. Membranes 
were incubated with the film in the 
darkroom for an initial period of 5 minutes, 
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followed by development of the film using 
a conventional 3- step solution system. 
Densitometry: In order to compare protein 
levels, optical density of bands can be 
measured using the FlourS Multi Imager, 
and the Quantity One analysis software 
(Bio-Rad). The data is normalised by 
dividing each value by the value obtained 
from each loading control.  
 
Immunocytochemistry (ICC) 
In order to show intracellular localisation of 
Wave proteins and to investigate possible 
co-localisation. Cells were grown on poly-
lysine/laminin coated Lab-tek slides, in 
growth medium. After 3 days, cells were 
fixed with paraformaldehyde (PFA 4%) for 
10 minutes at room temperature. 
Following the standard protocol cells were 
washed with TBS, incubated with 0.2% 
Triton/PBS for 5 minutes at room 
temperature, washed 3 times with TBS for 
5 minutes before blocking with 10% NGS 
1%BSA TBS for 45 minutes at room 
temperature. After washing cells with TBS  
for 5 minutes at room temperature, slides 
were incubated with primary antibodies 
(anti Pan-Wave 1:100, anti-Wave-2 1:100, 
anti Rac1 1:100) (BD Bioscience) in 
1%BSA/TBS overnight at 4º C. 
TBS washing step (3 times 5 minutes) was 
followed by incubation with secondary 
antibodies (Goat-anti-mouse Alexa Fluor 
488 1:500 or Goat-anti-rabbit Cy3 1:500) 
in 1%BSA/TBS and AlexaFlour 488 
labelled Phalloidin (1:100) (Molecular 
Probes) to stain F-actin, for 40 minutes at 
room temperature. Following three final 
washing steps with TBS (5 minutes at 
room temperature) slides were covered 
and sealed using vecta shield.  
 
Confocal Microscopy 
Subsequent visualisation of fluorescently 
labelled structures and proteins within the 
cells was performed using a Zeiss 
meta510 confocal laser microscope, in 






Immunocytochemistry labelling for Factin 
to visualize the cytoskeleton and for Pan 
Wave was used to determine localisation 
and distribution of WAVE in both NF2+/+ 
and NF2-/-. The polarized Schwann cells 
showed Pan Wave mostly concentrated in 
the nucleus (Fig.2A), whereas NF2-/- 
displayed Pan Wave in the nucleus and 
the cytoplasm where Wave seems to co-
localise partly with actin filaments (Fig.2B). 
In order to verify the specificity of the Pan 
Wave antibody, western blots using NF2-/- 
lysate were performed. The western blot 
analysis for Pan-Wave using NF2-/- whole 
cell lysate revealed bands at 125 kDa, 84 
kDa and 50 KDa (Fig.3).  
 
Wave–2 
ICC labelling for Wave-2, F actin and Rac 
in NF2-/- schwannoma cells was carried 
out in order to determine localisation and 
distribution of Wave 2, and to investigate a 
potential co-localisation of Wave 2 with 
Rac1.  Wave 2 could be found in the 
nucleus and the cytoplasm (Fig.4A). 
Fig.4B and at higher magnification 
(Fig.4C) showed co-localisation (yellow) of 
Rac1 and Wave-2 at the membrane. 
Three pairs of NF2+/+ and NF2-/- at 
protein concentrations of 5µg and 10µg 
were used to investigate Wave 2 levels in 
both cell types. RhoGDI was used as a 
loading control. Wave-2 was expected to 
show a single band at 68 kDa. Western 
blots showed bands at around 75 kDa, 50 
kDa, 37 kDa and 30 kDa (Figure 5). Only a 
very weak band at 68kDa was detected, 
and protein levels between cell types 
could not be compared using densitometry 
analysis.  
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To analyse the specificity of the antibody, 
a control western blot using HL60 cell 
lysate and NF2-/- lysate was performed 
(Fig.6). Multiple bands, including a weak 
band at around 68 kDa, but a main band 
at around 40 kDa and one band at 30 kDa 
were detected. ICC in Schwann cells was 
not performed as the western blot analysis 
of Wave-2 showed multiple bands in the 
control lysate, indicative for non-specificity 




To investigate Wave expression and 
localisation in human primary 
schwannoma  
cells, a Pan-Wave antibody was used 
initially. Western blot analysis showed 
multiple bands among which was one at 
84 kDa as expected. Multiple bands can 
occur due to different reasons and as cell 
lysis and protein extraction involved boiling 
the samples; this could have lead to partial 
breakdown of the protein in question, and 
would offer some explanation to why the 
bands were lower than expected. Protease 
and phosphatase inhibitors contained in 
the lysis buffer should however prevent 
protein breakdown.  
Multiple bands can also be an indication 
for non-specificity of the Pan-Wave 
antibody. Specificity can be tested using a 
blocking peptide. The term “blocking 
peptide” refers to the original peptide 
against which the host produced 
antibodies, which subsequently are 
extracted from the blood serum. Blocking 
peptide however was not available for this 
antibody. In NF2-/- cells Pan-Wave 
colocalises with F-actin, which can be 
expected due to observed increase in 
actin remodelling in schwannoma cells. 
However, specificity of the antibody is in 
question, and therefore conclusions taken 
from this colocalisation are difficult. 
Moreover a nuclear stain in both cell types 
was observed. Wave has been put forward 
to have a potential role in regulation of 
nucleocytoskeleton dynamics as it has 
been observed in the nucleus (reviewed in 
Bompard & Caron, 2004). Nuclear staining 
however is also an indication for unspecific 
binding of the antibody, and taking into 
consideration the results from the western 
blot analysis this seems more likely. The 
Pan-Wave antibody is polyclonal, as a 
number of epitopes are recognised. Wave 
and WASP share the Arp2/3 binding 
domains (VDA module), and belong to the 
same family of proteins and share 85% 
homology. It is therefore possible that the 
Pan-Wave antibody binds any of these, 
very similar proteins. An isoform specific 
antibody (Wave-2) was expected to 
provide more specific results. Wave2 was 
chosen, since it is considered to be the 
major isoform in rat Schwann cells (Bacon 
et al., 2007).  
ICC labelling for Wave-2 showed some co-
localisation of Rac1 and Wave-2. This is to 
be expected as Rac1 binds and thereby 
activates Wave-2 at the membrane. 
Anti-Wave-2 was expected to give a single 
band at 68 kDa in western blots in HL-60 
cell (a leukocyte cell line) lysate according 
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to the manufacturer. Multiple bands 
obtained in western blots using Schwann 
and schwannoma cell lysates were lower 
than expected. To rule out errors within 
the method, HL-60 lysate was purchased 
and used to determine the antibody’s 
(Wave-2) specificity, by running a control 
western blot as described by the 
manufacturer. However this experiment 
also revealed several bands. A blocking 
peptide was not available for the Wave-2 
antibody. 
It is therefore not possible to verify any of 
the results obtained from the ICC as the 
antibody is not specific. For this reason 
ICC in Schwann cells was not performed.  
Since Wave proteins are bound in 
complexes it would be possible to 
investigate the expression and localisation 
of other proteins bound in the Wave-2 
complex, such as PIR121, Abi1 or Nap-1, 
but Abi1 in particular (Innocenti, M. et al., 
2004) in order to further test antibody 
specificity. 
Further experiments that circumvent the 
antibody problem could be used. For 
example, real-time PCR could be used to 
establish the main Wave isoform at mRNA 
level in both cell types NF2+/+ and NF2-/-. 
However, to investigate expression of the 
isoforms at protein levels, the use of 
antibodies is indispensable. As the quality 
of commercial Wave antibodies is in 
question, some research groups generate 
their own antibodies in rabbits and other 
rodents and therefore do not rely on 
commercial availability. Once work using a 
particular antibody has been published, 
sample aliquots can be obtained from 
these groups.  Another approach would be 
the generation of an own antibody. 
RNA Interference (RNAi), a technique to 
block a protein at transcriptional level, 
could be utilised to knock down Wave-2 
and investigate the effect on cell 
morphology in NF2-/- schwannoma cells.  
However this technique is known for its 
intricacy and brings other variables into 
consideration (Fire, A. et al., 1998).  
Further more results from N-WASp 
investigations (including blocking with 
wiskostatin) in human schwannoma cells 
(unpublished data) have indicated that 
upregulation / activation of the cytoskeletal 
regulatory proteins is a secondary effect 
following Rac and Cdc42 activation. 
Potential molecular targets for the 
treatment of Neurofibromatosis Type II are 
therefore likely to be upstream of Rac. 
Such a target could be PAK (Hirokawa et 
al., 2004), or GEFs and GAPs known to 
control GTPase activity, like Beta-Pix (ten 
Klooster et al., 2006). 
 
3D cell culture and the generation of 
spheroids, offer an approach to culture 
cells in a more lifelike environment for 
longer periods of time (some cells have 
been shown to retain key functions for 
weeks to months). As cells are able to 
interact, and form cell-to-cell junctions, 
they have been shown to behave 
differently in response to their 
microenvironment. Spheroids have been 
described to mimic in vivo functioning. 
This has proven particular useful in 
toxicological investigation preceding any 
clinical trials. However investigations are 
not restricted to this aspect and all known 
investigation methods known in biological 
sciences can be applied using spheroids. 
As for Schwann and schwannoma cells, 
3D culture method could be employed in 
addition to the existing model to further 
verify results gained from investigations. 
The equipment required to establish such 
a 3D culture model was estimated at 
around 10,000 GBP in addition to some 
expertise perhaps in the form of a PhD 
project (Xu, J. & Purcell, WM., 2006; Kim, 
SM. et al., 2007). 
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